MercadoLibre (NASDAQ: MELI), a leading e-commerce platform in Latin America, has seen its stock rise by 25% this year despite broader market struggles. The company, which provides a suite of fintech and logistics services, is well-positioned to weather economic volatility, largely unaffected by U.S. tariffs. Analysts predict continued revenue growth driven by the expanding e-commerce industry, which is expected to thrive into the next decade.
DexCom (NASDAQ: DXCM), known for its continuous glucose monitoring devices for diabetes management, also exhibits promising growth potential. With less than 1% of diabetes patients currently using CGM technology, DexCom anticipates market expansion and increased insurance coverage to drive future sales. The company has recently launched new products, including the G7 and a more affordable CGM option, to cater to diverse patient needs.
Investors looking for promising stocks during market volatility may find both MercadoLibre and DexCom to be attractive long-term options, as both companies are positioned well in their respective markets.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
